Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 1
Submit an article Journal homepage
89
Views
20
CrossRef citations to date
0
Altmetric
Brief Report

Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes

Carol WyshamRockwood Clinic Spokane, WAUSA
,
Cameron LushAmylin Pharmaceuticals, Inc. San Diego, CAUSA
,
Bei ZhangAmylin Pharmaceuticals, Inc. San Diego, CAUSA
,
Holly MaierAmylin Pharmaceuticals, Inc. San Diego, CAUSACorrespondence[email protected]
&
Ken WilhelmAmylin Pharmaceuticals, Inc. San Diego, CAUSA
Pages 79-85 | Accepted 24 Oct 2007, Published online: 20 Nov 2007

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Susan Cornell & Jennifer D'Souza. (2014) Pharmacotherapy Considerations in Diabetes and Obesity: Setting Patients up for Success. Postgraduate Medicine 126:2, pages 100-109.
Read now
Nancy J. V. Bohannon. (2012) Individualized Treatment of Type 2 Diabetes Mellitus Using Noninsulin Agents: Clinical Considerations for the Primary Care Physician. Postgraduate Medicine 124:4, pages 95-108.
Read now
Scott E. Nelson. (2011) Management of patients with type 2 diabetes. Current Medical Research and Opinion 27:10, pages 1931-1947.
Read now
Carol H. Wysham. (2010) New Perspectives in Type 2 Diabetes, Cardiovascular Risk, and Treatment Goals. Postgraduate Medicine 122:3, pages 52-60.
Read now
Gina Ryan, Tim A Briscoe & Lynette Jobe. (2008) Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes. Drug Design, Development and Therapy 2, pages 203-214.
Read now

Articles from other publishers (15)

Natalie C. Ward, Wann Jia Loh & Gerald F. Watts. 2023. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus 357 406 .
John Grizzanti, Rachel Corrigan & Gemma Casadesus. (2018) Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition. Journal of Alzheimer's Disease 66:1, pages 11-23.
Crossref
Kate Arkless, Fulye Argunhan & Susan D. Brain. 2019. Calcitonin Gene-Related Peptide (CGRP) Mechanisms. Calcitonin Gene-Related Peptide (CGRP) Mechanisms 1 12 .
Yong-Chao Qiao, Wei Ling, Yan-Hong Pan, Yin-Ling Chen, Dan Zhou, Yan-Mei Huang, Xiao-Xi Zhang & Hai-Lu Zhao. (2017) Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Oncotarget 8:39, pages 66504-66515.
Crossref
Kathrin Herrmann, Ming Zhou, Andrew Wang & Tjerk W. A. de Bruin. (2016) Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials. Clinical Diabetes and Endocrinology 2:1.
Crossref
Sidra Azim, William L. Baker & William B. White. (2014) Evaluating Cardiovascular Safety of Novel Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus. Current Cardiology Reports 16:11.
Crossref
Sandra J. Hamilton & Gerald F. Watts. 2014. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus 239 278 .
Elliott M. Groves, Katherine Yu, Nathan D. Wong & Shaista Malik. (2013) Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes Mellitus. Current Treatment Options in Cardiovascular Medicine 15:6, pages 706-721.
Crossref
Cristina M. Sena, Carla F. Bento, Paulo Pereira, Filipa Marques & Raquel Seiça. 2013. New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM 29 87 .
Mark Stolar. (2011) Addressing Cardiovascular Risk in Patients With Type 2 Diabetes: Focus on Primary Care. The American Journal of the Medical Sciences 341:2, pages 132-140.
Crossref
Ronald A. CodarioRonald A. Codario. 2011. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome 153 168 .
Michelle L. Griffith, Lisa M. Younk & Stephen N. Davis. (2010) Visceral Adiposity, Insulin Resistance, and Type 2 Diabetes. American Journal of Lifestyle Medicine 4:3, pages 230-243.
Crossref
Cristina M. Sena, Carla F. Bento, Paulo Pereira & Raquel Seiça. (2010) Diabetes mellitus: new challenges and innovative therapies. EPMA Journal 1:1, pages 138-163.
Crossref
J. Philippe & D. Raccah. (2009) Treating type 2 diabetes: how safe are current therapeutic agents?. International Journal of Clinical Practice 63:2, pages 321-332.
Crossref
Elizabeth W Blake & Julie M Sease. (2009) Effect of Diabetes Medications on Cardiovascular Risk and Surrogate Markers in Patients with Type 2 Diabetes. Journal of Pharmacy Technology 25:1, pages 24-36.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.